Search

Search Constraints

You searched for: Subject JAK-STAT pathway Remove constraint Subject: JAK-STAT pathway Start Over

Search Results

2. Long-term treatment with ruxolitinib for patients with myelofibrosis: 5-year update from the randomized, double-blind, placebo-controlled, phase 3 COMFORT-I trial